Article Versions Notes

Salvanou E-A, Stellas D, Tsoukalas C, Mavroidi B, Paravatou-Petsotas M, Kalogeropoulos N, Xanthopoulos S, Denat F, Laurent G, Bazzi R, et al. A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225. Pharmaceutics. 2020; 12(2):188. https://doi.org/10.3390/pharmaceutics12020188

Salvanou, Evangelia-Alexandra, Dimitris Stellas, Charalampos Tsoukalas, Barbara Mavroidi, Maria Paravatou-Petsotas, Nikolaos Kalogeropoulos, Stavros Xanthopoulos, Franck Denat, Gautier Laurent, Rana Bazzi, and et al. 2020. "A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225" Pharmaceutics 12, no. 2: 188. https://doi.org/10.3390/pharmaceutics12020188

Salvanou, E. -A., Stellas, D., Tsoukalas, C., Mavroidi, B., Paravatou-Petsotas, M., Kalogeropoulos, N., Xanthopoulos, S., Denat, F., Laurent, G., Bazzi, R., Roux, S., & Bouziotis, P. (2020). A Proof-of-Concept Study on the Therapeutic Potential of Au Nanoparticles Radiolabeled with the Alpha-Emitter Actinium-225. Pharmaceutics, 12(2), 188. https://doi.org/10.3390/pharmaceutics12020188